AUPH: Aurinia Pharmaceuticals Inc Kompaniya qiymatining sof foydaga nisbati

Aurinia Corp - AUPH emitenti grafik logotipi

Aurinia Pharmaceuticals (AUPH) immun dori vositalari sinovlarini tezlashtirish uchun raqamli biodata monitoringini joriy qilmoqda. Kompaniyaning GURU.Markets platformasidagi fundamental P/E ko'rsatkichi joriy holat 6.50 ekanligini ko'rsatmoqda va buni Lupkynis savdolarining o'sishi hamda aksiyalarni qayta sotib olish bilan izohlamoqda. Biznesning moliyaviy barqarorligi kapital xarajatlari va operatsion xarajatlarni to'liq qoplaydigan barqaror pul oqimi bilan tasdiqlanadi.

Aurinia Pharmaceuticals Inc. (AUPH) Narxning foydaga nisbati: 04.07.2022 - 17.11.2026 davri uchun

Aurinia Corp (AUPH) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Aurinia Pharmaceuticals Inc. AUPH
Aurinia Pharma brend mahsuloti

Aurinia Pharmaceuticals (AUPH) kompaniyasining barqarorligi uning tizimli qizil bo'g'imi nefriti terapiyasining joriy etilish dinamikasi va sezilarli likvidlik rezervi bilan ta'minlangan. Kompaniyaning P/E tarixida aks etgan bozor kapitalizatsiyasining tasdiqlangan sof foydaga nisbati investorlarga foyda birligi uchun xarajatlarni hamda 10-K yoki 10-Q hisobotlari e'lon qilingandan keyin bozorning qayta baholanish tezligini tahlil qilish imkonini beradi, bu esa joriy rentabellik va haddan tashqari to'lov qilish xavfi o'rtasidagi muvozanatni ochib beradi.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori biocryst.com|Narxning foydaga nisbati Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Narx-foyda multiplikatori|P/E multiplikatori PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Kapitalizatsiyaning foydaga nisbati|TRML: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati PGEN|PHAR: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nektar Therapeutics Inc (NKTR)|Narx-foyda koeffitsiyenti UPB|Narx-foyda multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx-foyda koeffitsiyenti IMNM (Immunome Bio)|Biznesning o‘zini qoplash muddati Gossamer Bio, Inc.|P/E multiplikatori KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Kapitalizatsiyaning foydaga nisbati|PVLA - Narxning foydaga nisbati|SVRA - P/E multiplikatori|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|ANAB - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ATXS|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris Therapeutics)|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|CABA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc) - Narxning foydaga nisbati|AVTX (Avalo Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals|Narxning foydaga nisbati Agenus Inc. (AGEN)|Narx-foyda koeffitsiyenti Climb Bio Inc. CLYM|P/E multiplikatori ZURA (Zura Bio Ltd)|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA - P/E multiplikatori|STTK: P/E multiplikatori|Equillium Bio (EQ) - P/E multiplikatori|CNTB (connectbiopharm.com) - P/E multiplikatori|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori adicetbio.com ACET|Celularity - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori